New Contraceptive Contract for ITDD

November 5, 2013

In fall 2013, Institute for Therapeutics Discovery & Development faculty were awarded an $8.3 million contract from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to investigate pharmaceutical alternatives to existing birth control methods.

The primary goal of the five-year research contract is to both develop new non-hormonal male and female birth control drug targets and expand on existing targets.

Categories: Health Sciences News